Back to Search
Start Over
Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial
- Source :
- The Lancet Respiratory Medicine; June 2022, Vol. 10 Issue: 6 p584-592, 9p
- Publication Year :
- 2022
-
Abstract
- The benefit of fractional exhaled nitric oxide (FeNO) in guiding asthma treatment is uncertain. We evaluated the efficacy of adding FeNO to symptom-guided treatment in children with asthma versus only symptom-guided treatment.
Details
- Language :
- English
- ISSN :
- 22132600 and 22132619
- Volume :
- 10
- Issue :
- 6
- Database :
- Supplemental Index
- Journal :
- The Lancet Respiratory Medicine
- Publication Type :
- Periodical
- Accession number :
- ejs58787255
- Full Text :
- https://doi.org/10.1016/S2213-2600(21)00486-0